Home / HSD17B6 Knockout Cell Lines

HSD17B6 Knockout Cell Lines

Gene: HSD17B6

Official Full Name: hydroxysteroid 17-beta dehydrogenase 6provided by HGNC

Gene Summary: The protein encoded by this gene has both oxidoreductase and epimerase activities and is involved in androgen catabolism. The oxidoreductase activity can convert 3 alpha-adiol to dihydrotestosterone, while the epimerase activity can convert androsterone to epi-androsterone. Both reactions use NAD+ as the preferred cofactor. This gene is a member of the retinol dehydrogenase family. [provided by RefSeq, Aug 2013]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO34013 HSD17B6 Knockout cell line (HCT 116) Human HSD17B6 1:2~1:4 Negative Online Inquiry
KO34014 HSD17B6 Knockout cell line (HEK293) Human HSD17B6 1:3~1:6 Negative Online Inquiry
KO34015 HSD17B6 Knockout cell line (A549) Human HSD17B6 1:3~1:4 Negative Online Inquiry

Background

HSD17B6 Gene Knockout Cell Lines are specialized, engineered cellular models designed for the targeted disruption of the HSD17B6 gene, which encodes for the enzyme 17β-hydroxysteroid dehydrogenase type 6. This enzymatic protein is primarily involved in the regulation of steroid hormone metabolism and plays a critical role in the biosynthesis and catabolism of estrogens and androgens. By generating knockout cell lines, researchers can investigate gene function, elucidate metabolic pathways, and better understand the physiological roles of HSD17B6 in various biological contexts.

These cell lines function through CRISPR/Cas9 mediated gene editing, ensuring precise deletions or modifications at the genetic level. As a result, they enable the study of the effects of HSD17B6 disruption on cellular signaling pathways, hormonal balance, and even cellular responses to therapeutic agents. The insight gained from using these knockout models is vital for advancing our knowledge of endocrine disorders, reproductive health, and hormone-related diseases, making them invaluable tools for both basic and translational research.

In clinical settings, HSD17B6 gene knockout cell lines facilitate drug discovery and development by providing new platforms for screening potential therapeutics targeting steroid metabolism. Compared to traditional cell lines, these knockout models offer unparalleled specificity and relevance, allowing researchers to delineate the precise contribution of HSD17B6 to pathological conditions.

Researchers and clinicians benefit from the high fidelity and reproducibility of HSD17B6 knockout cell lines, which are essential for obtaining accurate and reliable data. Additionally, these cell lines minimize off-target effects commonly associated with less sophisticated gene disruption techniques.

Our company prides itself on delivering top-quality biological products backed by extensive expertise in genomics and cell biology. As a trusted partner in research innovation, we are committed to equipping scientists with the tools they need to unlock new avenues in hormonal research and therapeutic development.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.